Location: Cambridge Neural Institute
Date: September 21, 2041
Fourteen Years Since the Collapse
The report was marked Level IV Internal Observation — Eyes Only.
But by now, everyone on the floor had seen it.
Dr. Lina Halvorsen stood at the center of a sealed observation lab, speaking into a voice recorder as two lab techs monitored the feeds behind glass. On the screen above her, a 3D rendering of a human brain spun slowly.
“Subject Delta-19 displays stable coupling between hypothalamic-pituitary output and limbic response. The synaptic silence that’s persisted in all post-collapse human samples is no longer present.”
She paused.
“To put it plainly—his brain is responding to sexually coded stimuli. Internally and externally. He’s the first.”
The breakthrough came after years of theoretical modeling. While hormone levels had remained normal in all subjects—estradiol, testosterone, luteinizing hormone—the connection between those hormones and actual impulse had gone dark.
Dead wire.
The phrase they'd started using was poetic, almost lazy:
The speaker is fine. The amplifier is fine. But the wire between them has vanished.
But now, with Delta-19, something had changed.
Halvorsen tapped the hologram display, highlighting the brainstem.
“We used CRISPR-type gene-editing tools combined with a new neurochemical primer—codenamed Neurofire—that remapped certain glial junctions in the preoptic area of the hypothalamus.”
“Essentially, we’ve rebuilt the bridge.”
One of the techs behind glass whispered to the other: “It worked?”
Halvorsen looked directly into the camera feed.
“It worked. He has a libido.”
The room was silent for several seconds.
“Is he... okay?” came a voice on the intercom.
“Not entirely,” Halvorsen said. “He’s lucid, but disoriented. Stimuli that once felt instinctive now feel alien. He reports attraction, fixation, restlessness. He called it a pull.”
She glanced down at her tablet.
“He also reports loneliness. That might be the most acute symptom.”
They hadn’t told him yet that no one else would understand. That he would be alone in his condition—isolated by a world that no longer spoke his language.
“What about reproduction markers?” the intercom asked.
“Everything functional,” Halvorsen replied. “Sperm count normal. Full tumescence. No artificial stimulation required.”
“And his behavior?”
“Not dangerous. But...” She hesitated. “Unfamiliar. Some of the staff said he looked at them strangely. Not hostile, just... focused. As if seeing something they didn’t.”
She didn’t add the obvious: that they hadn’t been looked at like that in decades.
Later that night, when the institute was dark and quiet, Halvorsen sat alone with the lab file glowing faintly on her screen. Her hand hovered over the escalation protocol:
Transfer to BioSecure Vault, Geneva. Lock classification at Tier Zero.
No press release.
No internal memo beyond the top five signatories.
No leak.
The drug would be moved before dawn. The subject would be sedated, relocated, and scrubbed from the personnel logs.
They weren’t going to ban libido.
They were going to pretend it had never been found.